Chi Chiu So
Overview
Explore the profile of Chi Chiu So including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheuk D, Lee P, Chan W, Chan G, So C, Leung W
Transpl Immunol
. 2025 Feb;
89:102176.
PMID: 39892768
Ex-vivo depletion of donor CD45RA+ naïve T-cells can reduce graft-versus-host-disease (GVHD) in haploidentical hematopoietic stem cell transplantation (HSCT) while providing memory T-cells to reduce infections. CD62L is another marker of...
2.
Tung K, Chen C, Chiu Y, So H, So C, Ip P
BMJ Paediatr Open
. 2024 Aug;
8(1).
PMID: 39209439
Background: Reticulocyte haemoglobin equivalent (RET-He) is a useful tool for evaluating recent iron usage irrespective of inflammatory status. This study aims to establish a reference for RET-He among Hong Kong...
3.
Wang H, Chan K, Cheng C, Ng M, Lee P, Cheng F, et al.
Blood Cancer Discov
. 2022 Aug;
3(6):516-535.
PMID: 35960210
Significance: We conducted integrated drug and genomic profiling of patient biopsies to build the functional genomic landscape of pediatric AML. Age-specific differences in drug response and new gene-drug interactions were...
4.
Tsang M, Ha S, Chan N, So C, Cheuk D, Chan G
Pediatr Blood Cancer
. 2022 Apr;
69(10):e29654.
PMID: 35389555
No abstract available.
5.
Ng H, Wan T, So C, Chim C
J Clin Pathol
. 2014 May;
67(7):626-31.
PMID: 24811488
Aim: TP53 mutation frequently occurs in solid cancers but not haematological cancers including acute promyelocytic leukaemia (APL) characterised by t(15;17). Both DAPK1 and p14(ARF) positively regulate p53 whereas miR-34a and...
6.
Wong K, Wan T, So C, Chim C
Cancer Cell Int
. 2013 Dec;
13(1):122.
PMID: 24330858
Background: A new human myeloma cell line, MMLAL, was established from the myelomatous pleural effusion of a 73-year-old Chinese patient suffering from symptomatic International stage III IgG/lambda myeloma. After a...
7.
Ng R, Kong C, So C, Lui W, Chan Y, Leung K, et al.
J Pathol
. 2013 Oct;
232(1):65-74.
PMID: 24122813
HOX genes are frequently dysregulated in human leukaemia with the gene rearrangement between mixed lineage leukaemia (MLL) and partner genes. The resultant MLL fusion proteins are known to mediate leukaemia...
8.
Wong K, Yim R, So C, Jin D, Liang R, Chim C
Blood
. 2011 Oct;
118(22):5901-4.
PMID: 21976676
We postulated that MIR34B/C, a direct transcriptional target of TP53, might be inactivated by promoter hypermethylation in multiple myeloma (MM). MIR34B/C promoter methylation was studied in 8 normal marrow controls,...
9.
Wong K, So C, Loong F, Chung L, Lam W, Liang R, et al.
PLoS One
. 2011 May;
6(4):e19027.
PMID: 21544199
miR-124-1 is a tumour suppressor microRNA (miR). Epigenetic deregulation of miRs is implicated in carcinogenesis. Promoter DNA methylation and histone modification of miR-124-1 was studied in 5 normal marrow controls,...